Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc. - PE Ratioverified

OCUL

Price:

$9.43

Market Cap:

$2.06B

Ocular Therapeutix, Inc. is a biopharmaceutical company specializing in the creation, advancement, and commercialization of ophthalmic treatments. Their innovative approach leverages a proprietary bioresorbable hydrogel technology to address a range of eye diseases and conditions. The company currently offers two key products: ReSure Sealant, an ophthalmic device designed to prevent fluid leakage from corneal incisions after cataract surgery, and DEXTENZA, a dexamethasone-based ophthalmic insert used to manage post-surgical inflammation and pain in the eye, as well as to treat allergic conjunctivitis. In addition to their commercial offerings, Ocular Therapeutix is actively developing severa...[Read more]

Industry

Biotechnology

IPO Date

2014-07-25

Stock Exchange

NASDAQ

Ticker

OCUL

The PE Ratio as of June 2026 (TTM) for Ocular Therapeutix, Inc. (OCUL) is -6.55

According to Ocular Therapeutix, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -6.55. This represents a change of -10.88% compared to the average of -7.35 of the last 4 quarters.

Ocular Therapeutix, Inc. (OCUL) Historical PE Ratio (quarterly & annually)

How has OCUL PE Ratio performed in the past?

The mean historical PE Ratio of Ocular Therapeutix, Inc. over the last ten years is -4.83. The current -6.55 PE Ratio has changed 13.45% with respect to the historical average. Over the past ten years (40 quarters), OCUL's PE Ratio was at its highest in in the December 2019 quarter at -1.83. The PE Ratio was at its lowest in in the March 2021 quarter at -15.19.

Quarterly (TTM)
Annual

Average

-4.83

Median

-4.37

Minimum

-8.55

Maximum

-2.02

Ocular Therapeutix, Inc. (OCUL) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Ocular Therapeutix, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 290.99%

Maximum Annual PE Ratio = -2.02

Minimum Annual Increase = -59.30%

Minimum Annual PE Ratio = -8.55

Quarterly (TTM)
Annual
YearPE RatioChange
2025-8.5522.13%
2024-7.0071.08%
2023-4.0951.44%
2022-2.70-59.30%
2021-6.64-17.91%
2020-8.09290.99%
2019-2.07-18.42%
2018-2.5425.33%
2017-2.02-56.50%
2016-4.65-15.14%

Ocular Therapeutix, Inc. (OCUL) Average PE Ratio

How has OCUL PE Ratio performed in the past?

The current PE Ratio of Ocular Therapeutix, Inc. (OCUL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-6.55

5-year avg

-5.80

10-year avg

-4.83

Ocular Therapeutix, Inc. (OCUL) PE Ratio vs. Peers

How is OCUL’s PE Ratio compared to its peers?

Ocular Therapeutix, Inc.’s PE Ratio is greater than uniQure N.V. (-13.19), less than Galapagos N.V. (3.32), greater than Structure Therapeutics Inc. (-16.86), greater than Edgewise Therapeutics, Inc. (-22.17), less than Viridian Therapeutics, Inc. (-4.78), greater than Mesoblast Limited (-23.50), greater than Cogent Biosciences, Inc. (-11.21), greater than Arcus Biosciences, Inc. (-7.68), less than Liquidia Corporation (297.24), greater than ImmunityBio, Inc. (-8.62),

Build a custom stock screener for Ocular Therapeutix, Inc. (OCUL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ocular Therapeutix, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ocular Therapeutix, Inc. (OCUL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ocular Therapeutix, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Ocular Therapeutix, Inc.'s PE Ratio?

How is the PE Ratio calculated for Ocular Therapeutix, Inc. (OCUL)?

What is the highest PE Ratio for Ocular Therapeutix, Inc. (OCUL)?

What is the 3-year average PE Ratio for Ocular Therapeutix, Inc. (OCUL)?

What is the 5-year average PE Ratio for Ocular Therapeutix, Inc. (OCUL)?

How does the current PE Ratio for Ocular Therapeutix, Inc. (OCUL) compare to its historical average?